サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1420160

北米のグルコースモニタリングデバイス市場、2030年までの予測 - 地域別分析：タイプ別、用途別、検査タイプ別、エンドユーザー別

North America Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type, Application, Testing Type, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 99 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
北米のグルコースモニタリングデバイス市場、2030年までの予測 - 地域別分析：タイプ別、用途別、検査タイプ別、エンドユーザー別
出版日: 2023年12月04日
発行: The Insight Partners
ページ情報: 英文 99 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のグルコースモニタリングデバイス市場は、2022年の59億8,778万米ドルから、2030年までには144億958万米ドルに成長すると予測されています。2022年から2030年までのCAGRは11.6%と推定されます。

グルコースモニタリングデバイスの急速な技術進歩が北米のグルコースモニタリングデバイス市場を後押し

先進技術を搭載した製品は、糖尿病治療においてより効果的な利点を提供します。糖尿病の有病率が世界的に増加するにつれて、より高度な製品を求める需要も加速しています。そのため、研究者たちは長年にわたって製品の革新につながる研究活動を続けています。インスリンを体内に投与する方法には、注射針、インスリンペン、インスリンポンプなどがあります。インスリンポンプは、皮膚の下にカニューレで接続された小型のコンピュータ化された糖尿病管理装置で、ゆっくりと持続的にインスリンレベルを供給します。個人は、要求に応じてプログラムを制御することができます。最適な糖尿病管理は、正確なグルコースモニタリングデバイスにかかっています。グルコースモニタリングデバイスの進歩が進むにつれ、必要な血液量が少なくなり、精度も向上しています。血糖測定器とグルコースモニタリングデバイス間のデータ転送能力も向上しています。血糖モニタリング技術のますますの進歩により、精度が向上し、必要な血液量が少なくなり、血糖測定器とグルコースモニタリングデバイス間でデータを転送する能力も向上しています。2022年6月、Abbottは1つのセンサーでグルコースとケトンレベルを連続的にモニターする新しいバイオウェアラブルを発表しました。このように、技術的進歩と新製品の流入の増加が相まって、予測数年間の市場成長を促進すると予想されます。

北米のグルコースモニタリングデバイス市場概要

北米のグルコースモニタリングデバイス市場は、米国、カナダ、メキシコにセグメント化されています。この地域の市場成長は、糖尿病有病率の上昇、高齢者人口の増加が市場成長にプラスの影響を与える主な要因です。さらに、モニタリングデバイスの技術的進歩は、2022年から2030年の市場全体の成長をさらに促進します。

北米のグルコースモニタリングデバイス市場の2030年までの収益と予測

北米のグルコースモニタリングデバイス市場セグメンテーション

北米のグルコースモニタリングデバイス市場は、タイプ、用途、検査部位、エンドユーザー、および国にセグメント化されます。

タイプ別では、北米のグルコースモニタリングデバイス市場は、連続グルコースモニタリングデバイスと自己グルコースモニタリングデバイスにセグメント化されます。2022年の北米のグルコースモニタリングデバイス市場では、自己グルコースモニタリングデバイスセグメントが大きなシェアを占めています。

用途別では、北米のグルコースモニタリングデバイス市場は1型糖尿病と2型糖尿病に区分されます。2型糖尿病セグメントは2022年に北米のグルコースモニタリングデバイス市場でより大きなシェアを占めました。

検査部位別では、北米のグルコースモニタリングデバイス市場は指先検査と代替部位検査に区分されます。2022年の北米のグルコースモニタリングデバイス市場では、指先検査セグメントが大きなシェアを占めています。

エンドユーザー別では、北米のグルコースモニタリングデバイス市場はヘルスケア環境とセルフ/ホームケアにセグメント化されます。セルフ/ホームケアセグメントは、2022年に北米のグルコースモニタリングデバイス市場でより大きなシェアを占めました。

国別では、北米のグルコースモニタリングデバイス市場は、米国、カナダ、メキシコにセグメント化されます。米国が2022年の北米のグルコースモニタリングデバイス市場を独占しました。

B.Braun SE、F. Hoffmann-La Roche Ltd、LifeScan Inc、Medtronic Plc、Abbott Laboratories、Ypsomed Holding AG、Senseonics Holdings Inc、Nipro Corp、GE HealthCare Technologies Inc、Terumo Corpは、北米のグルコースモニタリングデバイス市場で事業を展開している主要企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米のグルコースモニタリングデバイス市場 - 主要産業力学

  • 主な市場促進要因
    • 糖尿病罹患率の上昇
    • 高齢者人口の増加
    • 肥満の有病率の増加
  • 主な市場抑制要因
    • グルコースモニタリングデバイスの高コスト
  • 主な市場機会
    • 新興諸国における医療ツーリズムの成長
  • 今後の動向
    • グルコースモニタリングデバイスの急速な技術進歩

第5章 グルコースモニタリングデバイス市場：北米市場分析

  • 北米のグルコースモニタリングデバイス市場の収益シェア、2022年～2030年

第6章 北米のグルコースモニタリングデバイス市場 - 2030年までの収益と予測：タイプ別

  • 北米のグルコースモニタリングデバイス市場の収益シェア、2022年・2030年：タイプ別（%）
  • 持続グルコースモニタリングデバイス
  • 自己血糖モニタリング機器

第7章 北米のグルコースモニタリングデバイス市場 - 2030年までの収益と予測：用途別

  • 北米のグルコースモニタリングデバイス市場の収益シェア、2022年・2030年：用途別（%）
  • 1型糖尿病
  • 2型糖尿病

第8章 北米のグルコースモニタリングデバイス市場 - 2030年までの収益と予測：検査部位別

  • 北米のグルコースモニタリングデバイス市場の収益シェア、2022年・2030年：検査部位別（%）
  • 指先検査
  • 代替部位検査

第9章 北米のグルコースモニタリングデバイス市場 - 2030年までの収益と予測：エンドユーザー別

  • 北米のグルコースモニタリングデバイス市場の収益シェア、2022年・2030年：エンドユーザー別（%）
  • ヘルスケア
  • セルフケア/ホームケア

第10章 北米のグルコースモニタリングデバイス市場 - 2030年までの収益と予測：国別分析

  • 北米：グルコースモニタリングデバイス市場

第11章 業界情勢

  • 北米のグルコースモニタリングデバイス市場における成長戦略
  • 有機的展開
  • 無機的展開

第12章 企業プロファイル

  • B. Braun SE
  • F. Hoffmann-La Roche Ltd
  • LifeScan Inc
  • Medtronic Plc
  • Abbott Laboratories
  • Ypsomed Holding AG
  • Senseonics Holdings Inc
  • Nipro Corp
  • GE HealthCare Technologies Inc
  • Terumo Corp

第13章 付録

図表

List Of Tables

  • Table 1. North America Glucose Monitoring Devices Market Segmentation
  • Table 2. Prevalence of diabetes worldwide, 2021
  • Table 3. US Glucose Monitoring Devices Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US Glucose Monitoring Devices Market, by Continuous Glucose Monitoring Devices by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Glucose Monitoring Devices Market, by Self-Glucose Monitoring Devices- Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Glucose Monitoring Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Glucose Monitoring Devices Market, by Testing Site - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Glucose Monitoring Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada Monitoring Devices Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Monitoring Devices Market, For Continuous Glucose Monitoring Devices- Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Monitoring Devices Market, For Self-Glucose Monitoring Devices- Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Monitoring Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada Monitoring Devices Market, by Testing Site - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Monitoring Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico North America Glucose Monitoring Devices Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico North America Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico North America Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Mexico North America Glucose Monitoring Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico North America Glucose Monitoring Devices Market, by Testing Site - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico North America Glucose Monitoring Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Organic Developments Done by Companies
  • Table 22. Inorganic Developments Done by Companies
  • Table 23. Glossary of Terms, North America North America Glucose Monitoring Devices Market

List Of Figures

  • Figure 1. North America Glucose Monitoring Devices Market Segmentation, By Country
  • Figure 2. North America North America Glucose Monitoring Devices Market: Key Industry Dynamics
  • Figure 3. North America North America Glucose Monitoring Devices Market: Impact Analysis of Drivers and Restraints
  • Figure 4. North America Glucose Monitoring Devices Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. North America Glucose Monitoring Devices Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 6. Continuous Glucose Monitoring Devices: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Sensors: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Transmitters: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Receivers: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Self-Glucose Monitoring Devices: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Testing Strips: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Glucose Meters: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Lancets: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. North America Glucose Monitoring Devices Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Type 1 Diabetes: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Type 2 Diabetes: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. North America Glucose Monitoring Devices Market Revenue Share, by Testing Site 2022 & 2030 (%)
  • Figure 19. Fingertip Testing: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Alternate Site Testing: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. North America Glucose Monitoring Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 22. Healthcare Settings: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Self/Homecare: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: North America North America Glucose Monitoring Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America: North America North America Glucose Monitoring Devices Market, by Country, 2022 & 2030 (%)
  • Figure 26. US: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Canada: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Mexico Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Growth Strategies in the North America North America Glucose Monitoring Devices Market
目次
Product Code: BMIRE00029122

The North America glucose monitoring devices market is expected to grow from US$ 5,987.78 million in 2022 to US$ 14,409.58 million by 2030. It is estimated to grow at a CAGR of 11.6% from 2022 to 2030.

Rapid Technological Advancements in Glucose Monitoring Devices Fuel North America Glucose Monitoring Devices Market

Products with advanced technologies offer more effective benefits in diabetes treatment. As the prevalence of diabetes increases worldwide, the demand for more products with advancements also accelerates. Thus, researchers have been carrying out research activities resulting in product innovations over the years. There are many methods to deliver insulin into the body, such as needles, insulin pens, and insulin pumps. Insulin pumps are small, computerized diabetes management devices connected with a cannula under the skin to deliver a slow, continuous insulin level. The individual can control the program depending on the requirements. Optimal diabetes management depends on accurate glucose monitoring devices. The increasing advancements in glucose monitoring devices have resulted in smaller required blood volumes with improved accuracy. The ability to transfer data between the blood glucose meter and glucose monitoring devices has also been improved. The increasing advancements in blood glucose monitoring technology have improved accuracy, smaller required blood volumes, and the ability to transfer data between the blood glucose meter and glucose monitoring devices. In June 2022, Abbott announced a new bio wearable that continuously monitors glucose and ketone levels in one sensor. Thus, the technological advancements coupled with the increasing influx of new products are expected to propel the market growth over the forecast years.

North America Glucose Monitoring Devices Market Overview

The North America North America glucose monitoring devices market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising diabetic prevalence, and increasing geriatric population are main factors positively influencing the growth of the market. Additionally, technological advancements in monitoring devices further enhances the overall market growth during 2022-2030.

North America Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Glucose Monitoring Devices Market Segmentation

The North America glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the North America glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on application, the North America glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on testing site, the North America glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on end user, the North America glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on country, the North America glucose monitoring devices market is segmented int o the US, Canada, and Mexico. The US dominated the North America glucose monitoring devices market in 2022.

B. Braun SE, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Senseonics Holdings Inc, Nipro Corp, and GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the North America glucose monitoring devices market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America glucose monitoring devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in North America glucose monitoring devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Glucose Monitoring Devices Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Incidence of Diabetes
    • 4.1.2 Growing Geriatric Population
    • 4.1.3 Increasing Prevalence of Obesity
  • 4.2 Key Market Restraints
    • 4.2.1 High Cost of Glucose Monitoring Devices
  • 4.3 Key Market Opportunities
    • 4.3.1 Growing Medical Tourism in Developing Countries
  • 4.4 Future Trends
    • 4.4.1 Rapid Technological Advancements in Glucose Monitoring Devices

5. Glucose Monitoring Devices Market - North America Market Analysis

  • 5.1 North America Glucose Monitoring Devices Market Revenue (US$ Mn), 2022 - 2030

6. North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Type

  • 6.1 Overview
  • 6.2 North America Glucose Monitoring Devices Market Revenue Share, by Type 2022 & 2030 (%)
  • 6.3 Continuous Glucose Monitoring Devices
    • 6.3.1 Overview
    • 6.3.2 Continuous Glucose Monitoring Devices: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Sensors
        • 6.3.2.1.1 Sensors: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.2 Transmitters
        • 6.3.2.2.1 Transmitters: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.3 Receivers
        • 6.3.2.3.1 Receivers: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Self-Glucose Monitoring Devices
    • 6.4.1 Overview
    • 6.4.2 Self-Glucose Monitoring Devices: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Testing Strips
        • 6.4.2.1.1 Testing Strips: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.2 Glucose Meters
        • 6.4.2.2.1 Glucose Meters: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.3 Lancets
        • 6.4.2.3.1 Lancets: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.4 Others
        • 6.4.2.4.1 Others: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 North America Glucose Monitoring Devices Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Type 1 Diabetes
    • 7.3.1 Overview
    • 7.3.2 Type 1 Diabetes: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Type 2 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Type 2 Diabetes: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Testing Site

  • 8.1 Overview
  • 8.2 North America Glucose Monitoring Devices Market Revenue Share, by Testing Site 2022 & 2030 (%)
  • 8.3 Fingertip Testing
    • 8.3.1 Overview
    • 8.3.2 Fingertip Testing: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Alternate Site Testing
    • 8.4.1 Overview
    • 8.4.2 Alternate Site Testing: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 North America Glucose Monitoring Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Healthcare Settings
    • 9.3.1 Overview
    • 9.3.2 Healthcare Settings: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Self/Homecare
    • 9.4.1 Overview
    • 9.4.2 Self/Homecare: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 -Country Analysis

  • 10.1 North America: Glucose Monitoring Devices Market
    • 10.1.1 Overview
    • 10.1.2 North America: Glucose Monitoring Devices Market , by Country
      • 10.1.2.1 US: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 US: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.3 US: North America Glucose Monitoring Devices Market , by Type, 2020-2030 (US$ Million)
        • 10.1.2.1.3.1 US: North America Glucose Monitoring Devices Market , by Continuous Glucose Monitoring Devices, 2020-2030 (US$ Million)
        • 10.1.2.1.3.2 US: North America Glucose Monitoring Devices Market , by Self-Glucose Monitoring Devices, 2020-2030 (US$ Million)
        • 10.1.2.1.4 US: North America Glucose Monitoring Devices Market , by Application, 2020-2030 (US$ Million)
        • 10.1.2.1.5 US: North America Glucose Monitoring Devices Market , by Testing Site, 2020-2030 (US$ Million)
        • 10.1.2.1.6 US: North America Glucose Monitoring Devices Market , by End User, 2020-2030 (US$ Million)
      • 10.1.2.2 Canada: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Canada: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.3 Canada Glucose Monitoring Devices Market , by Type, 2020-2030 (US$ Million)
        • 10.1.2.2.3.1 Canada Glucose Monitoring Devices Market , For Continuous Glucose Monitoring Devices, 2020-2030 (US$ Million)
        • 10.1.2.2.3.2 Canada Glucose Monitoring Devices Market , For Self-Glucose Monitoring Devices, 2020-2030 (US$ Million)
        • 10.1.2.2.4 Canada Glucose Monitoring Devices Market , by Application, 2020-2030 (US$ Million)
        • 10.1.2.2.5 Canada Glucose Monitoring Devices Market , by Testing Site, 2020-2030 (US$ Million)
        • 10.1.2.2.6 Canada Glucose Monitoring Devices Market , by End User, 2020-2030 (US$ Million)
      • 10.1.2.3 Mexico Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Canada: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.3 Mexico Glucose Monitoring Devices Market , by Type, 2020-2030 (US$ Million)
        • 10.1.2.3.3.1 Mexico Glucose Monitoring Devices Market , For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
        • 10.1.2.3.3.2 Mexico Glucose Monitoring Devices Market , For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
        • 10.1.2.3.4 Mexico Glucose Monitoring Devices Market , by Application, 2020-2030 (US$ Million)
        • 10.1.2.3.5 Mexico Glucose Monitoring Devices Market , by Testing Site, 2020-2030 (US$ Million)
        • 10.1.2.3.6 Mexico Glucose Monitoring Devices Market , by End User, 2020-2030 (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the North America North America Glucose Monitoring Devices Market
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.1 Inorganic Developments
    • 11.1.1 Overview

12. Company Profiles

  • 12.1 B. Braun SE
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 F. Hoffmann-La Roche Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 LifeScan Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Medtronic Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Abbott Laboratories
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Ypsomed Holding AG
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Senseonics Holdings Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Nipro Corp
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 GE HealthCare Technologies Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Terumo Corp
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms